Reviewed profile

food and beverage brand · public preview

Wegovy

Retail brand

Public category
Retail brand
Brand tier
mainstream brand
Headquarters
Denmark
Is this your company?Claim Wegovy to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to Wegovy — no cold outreach.
Report a changeLog in for full recordLast reviewed 26 Mar 2026 · public preview data

Overview

What Wegovy covers.

Wegovy is a prescription medication containing semaglutide, indicated for chronic weight management in adults and adolescents with obesity or overweight. Developed by Novo Nordisk, the treatment is available as both a once-weekly injectable pen and a once-daily oral tablet. It is also FDA-approved to reduce the risk of major cardiovascular events in adults with established heart disease and obesity or overweight.

  • Positioned as a mainstream brand.
  • Headquartered in Denmark.

FAQ

Questions this page answers.

What does Wegovy do?

Wegovy is a food and beverage brand based in Denmark, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Claim this pageLog in for full recordReport a change

Public preview data only · proprietary metrics remain in authenticated Talio.